Active Ingredient: BELUMOSUDIL MESYLATE
Proprietary Name: REZUROCK
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 200MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214783
Product Number: 001
Approval Date: Jul 16, 2021
Applicant Holder Full Name: KADMON PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information